These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34768791)

  • 1. Hepatocarcinogenesis Prevention by Pirfenidone Is PPARγ Mediated and Involves Modification of Nuclear NF-kB p65/p50 Ratio.
    Silva-Gomez JA; Galicia-Moreno M; Sandoval-Rodriguez A; Miranda-Roblero HO; Lucano-Landeros S; Santos A; Monroy-Ramirez HC; Armendariz-Borunda J
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hesperidin protects against chemically induced hepatocarcinogenesis via modulation of Nrf2/ARE/HO-1, PPARγ and TGF-β1/Smad3 signaling, and amelioration of oxidative stress and inflammation.
    Mahmoud AM; Mohammed HM; Khadrawy SM; Galaly SR
    Chem Biol Interact; 2017 Nov; 277():146-158. PubMed ID: 28935427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-β1/Smad3 pathway.
    Ying H; Fang M; Hang QQ; Chen Y; Qian X; Chen M
    J Cell Mol Med; 2021 Sep; 25(18):8662-8675. PubMed ID: 34327818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
    Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M
    Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
    Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
    Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
    [No Abstract]   [Full Text] [Related]  

  • 6. Umbelliferone Ameliorates CCl
    Mahmoud AM; Hozayen WG; Hasan IH; Shaban E; Bin-Jumah M
    Inflammation; 2019 Jun; 42(3):1103-1116. PubMed ID: 30741365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
    Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
    BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
    Zhou C; Zeldin Y; Baratz ME; Kathju S; Satish L
    BMC Musculoskelet Disord; 2019 Mar; 20(1):135. PubMed ID: 30927912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor γ Impairs Nuclear Export of Nuclear Factor-κB p65 in Vascular Smooth Muscle.
    Mukohda M; Lu KT; Guo DF; Wu J; Keen HL; Liu X; Ketsawatsomkron P; Stump M; Rahmouni K; Quelle FW; Sigmund CD
    Hypertension; 2017 Jul; 70(1):174-182. PubMed ID: 28507170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways.
    Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y
    Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
    Zhang N; Chu ES; Zhang J; Li X; Liang Q; Chen J; Chen M; Teoh N; Farrell G; Sung JJ; Yu J
    Oncotarget; 2014 Sep; 5(18):8330-40. PubMed ID: 25327562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2.
    Antar SA; Saleh MA; Al-Karmalawy AA
    Life Sci; 2022 Nov; 309():121048. PubMed ID: 36209833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro.
    Wei Q; Kong N; Liu X; Tian R; Jiao M; Li Y; Guan H; Wang K; Yang P
    J Transl Med; 2021 Apr; 19(1):157. PubMed ID: 33874948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
    Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
    Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pirfenidone Reverts Global DNA Hypomethylation, Promoting DNMT1/UHRF/PCNA Coupling Complex in Experimental Hepatocarcinoma.
    Miranda-Roblero HO; Saavedra-Salazar LF; Galicia-Moreno M; Arceo-Orozco S; Caloca-Camarena F; Sandoval-Rodriguez A; García-Bañuelos J; Frias-Gonzalez C; Almeida-López M; Martínez-López E; Armendariz-Borunda J; Monroy-Ramirez HC
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARα) in human hepatocarcinoma HepG2 cells by activation of NF-κB pathway.
    Lim WS; Ng DL; Kor SB; Wong HK; Tengku-Muhammad TS; Choo QC; Chew CH
    Cytokine; 2013 Jan; 61(1):266-74. PubMed ID: 23141142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
    Yu J; Shen B; Chu ES; Teoh N; Cheung KF; Wu CW; Wang S; Lam CN; Feng H; Zhao J; Cheng AS; To KF; Chan HL; Sung JJ
    Hepatology; 2010 Jun; 51(6):2008-19. PubMed ID: 20512989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morin modulates the oxidative stress-induced NF-kappaB pathway through its anti-oxidant activity.
    Kim JM; Lee EK; Park G; Kim MK; Yokozawa T; Yu BP; Chung HY
    Free Radic Res; 2010 Apr; 44(4):454-61. PubMed ID: 20187708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
    Zhao XY; Zeng X; Li XM; Wang TL; Wang BE
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):963-8. PubMed ID: 19413596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costunolide inhibits pulmonary fibrosis via regulating NF-kB and TGF-β
    Liu B; Rong Y; Sun D; Li W; Chen H; Cao B; Wang T
    Biochem Biophys Res Commun; 2019 Mar; 510(2):329-333. PubMed ID: 30709583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.